US Patent Issued to 1ST Biotherapeutics on May 20 for "Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof" (South Korean Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,905, issued on May 20, was assigned to 1ST Biotherapeutics Inc. (Gyeonggi-do, South Korea).

"Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof" was invented by Jinhwa Lee (Gyeonggi-do, South Korea) and Suyeon Jo (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides polymorphic forms and salts of (1S,2S)-2-fluoro-N-(6-(4-methylpyridin-3-yl)benzo[d]thiazol-2-yl)cyclopropane-1-carboxamide, pharmaceutical compositions comprising the compounds, processes for preparation of the compounds, and methods for treating neurodegenerative disorders."

The patent was fi...